QUALCOMM Incorporated (QCI)
XETRA Stock Exchange · Germany · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 155.90 |
|---|---|
| 52-week range | 106.06 – 222.40 |
| Return, 1 month / 3 months | −9.1% / +0.8% |
| Return, 1 year / 3 years | +10.1% / +60.7% |
| Trend | Uptrend |
| RSI (14) | 47 |
| Volatility (1 year) | 55.9% |
| Worst drawdown (1 year) | -40.3% |
| Average daily value traded | 0.49M EUR |
| Dividend yield | 1.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Qualcomm Incorporated designs chips and wireless technology used in mobile devices and many other connected products. Its Snapdragon processors and modems power smartphones and tablets, and its technology also appears in cars, networking gear and wearable devices. The company earns money both by selling these chips and by licensing its patent portfolio, which covers cellular and other wireless standards, to manufacturers around the world. Qualcomm is based in San Diego, California, in the United States.
On this site QUALCOMM Incorporated appears as a stock on the XETRA Stock Exchange (Germany), code QCI, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
QUALCOMM Incorporated (QCI) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 155.90 on 22 October 2026.
Its price-based Market X-Ray is 56 out of 100 (a fair price profile), ranking 316 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 10.1% and over the last three months it rose 0.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 60 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 6.7% | ||
| From 52-week high | -27.9% | ||
| Momentum | 75 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 0.8% | ||
| 6-month return | 35.5% | ||
| 12-month return, skipping the last month | 21.1% | ||
| Stability (higher is calmer) | 25 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 55.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -40.3% | ||
| Liquidity | 65 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.49M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 63 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 1.8% | ||
| Years with dividends | 6 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −0.7% |
|---|---|
| 1 month | −9.1% |
| 3 months | +0.8% |
| 6 months | +35.5% |
| 1 year | +10.1% |
| 3 years | +60.7% |
| 5 years | +52.6% |
Signals
| 50-day / 200-day average | 153.78 / 146.13 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 5.08 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 3 Sep 2026 | USD 0.8183 |
| 4 Jun 2026 | USD 0.8183 |
| 5 Mar 2026 | USD 0.7917 |
| 4 Dec 2025 | USD 0.7917 |
| 4 Sep 2025 | USD 0.7917 |
| 5 Jun 2025 | USD 0.7917 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.